A coronavirus vaccine begins clinical trials Monday — but it could be well over a year before you can get it

Hopefully the coronavirus vaccine is developed soon.
(Image credit: iStock)

A clinical trial testing a vaccine that could potentially protect against the novel coronavirus will begin Monday, The Associated Press reports. That will be the day that a human patient receives his or her dose of the experimental vaccine.

Vaccines take between a year and 18 months to be fully validated, public health officials told the AP. But "the traditional vaccine timeline is 15 to 20 years. That would not be acceptable here," Mark Feinberg, the president and CEO of the International AIDS Vaccine Initiative, recently told STAT. "When you hear predictions about it taking at best a year or a year and a half to have a vaccine available … there's no way to come close to those timelines unless we take new approaches."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Jeva Lange

Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.